Amiodarone-associated Optic Neuropathy—A Clinical Criteria–based Diagnosis?

References

• McKenna WJ, Oakley CM, Krikler DM, Goodwin JF. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985;53:412–416.
   PubMedGoogle Scholar
• Naccarelli GV, Wolbrette DL, Patel HM, Luck JC. Amiodarone: clinical trials. Curr Opin Cardiol 2000;15:64–72.
   PubMed Web of Science ®Google Scholar
• Chen D, Hedges TR. Amiodarone optic neuropathy—review. Semin Ophthalmol 2003;18:169–173.
   PubMedGoogle Scholar
• Murphy MA, Murphy JF. Amiodarone and optic neuropathy: the heart of the matter. J Neuroophthalmol 2005;25:232–236.
   PubMed Web of Science ®Google Scholar
• Turdumambetova G, Bredehorn T, Duncker GIW. Okuläre Nebenwirkungen der Amiodaron-Therapie. Klin Monbl Augenheilkd 2005;222:485–492.
   PubMed Web of Science ®Google Scholar
• Eryilmaz T, Atilla H, Batioglu F, Günalp I. Amiodarone-related optic neuropathy. Jpn J Ophthalmol 2000;44:565–568.
   PubMed Web of Science ®Google Scholar
• Feiner LA, Younge BR, Kazmier FJ, Sticker BH, Fraunfelder FT. Optic neuropathy and amiodarone therapy. Mayo Clin Proc 1987;62:702–717.
   PubMed Web of Science ®Google Scholar
• Garrett SN, Kearney JJ, Schiffman JS. Amiodarone optic neuropathy. J Neuroophthalmol 1988;8:105–110.
   Google Scholar
• Gittinger JW, Asdourian GK. Papillopathy caused by amiodarone. Arch Ophthalmol 1987;105:349–351.
   PubMedGoogle Scholar
• Leifert D, Hansen LL, Gerling J. [Amiodarone-associated optic neuropathy: an independent syndrome? Three patients with bilateral optic neuropathy]. Klin Monbl Augenheilkd 2000;217:171–177.
   PubMed Web of Science ®Google Scholar
• Mäntyjärvi M, Tuppurainen K, Ikäheimo K. Ocular side effects of amiodarone. Surv Ophthalmol 1998;42:360–366.
   PubMed Web of Science ®Google Scholar
• Nagra PK, Foroozan R, Savino PJ, Castillo I, Sergott RC. Amiodarone induced optic neuropathy. Br J Ophthalmol 2003;87:420–422.
   PubMed Web of Science ®Google Scholar
• Nazarian SM, Jay WM. Bilateral optic neuropathy associated with amiodarone therapy. J Clin Neuroophthalmol 1988;8:25–28.
   PubMedGoogle Scholar
• Shinder R, Frohman LP, Turbin RE. Regression of bilateral optic disc edema after discontinuation of amiodarone. J Neuroophthalmol 2006;26:192–194.
   PubMed Web of Science ®Google Scholar
• Speicher MA, Goldman MH, Chrousos GA. Amiodarone optic neuropathy without disc edema. J Neuroophthalmol 2000;20:171–172.
   PubMed Web of Science ®Google Scholar
• Sreih AG, Schoenfeld MH, Marieb MA. Optic neuropathy following amiodarone therapy. Pacing Clin Electrophysiol 1999;22:1108–1110.
   PubMed Web of Science ®Google Scholar
• Uebermuth CA, Gerke E. First unilateral, later bilateral optic neuropathy. Amiodarone as the cause? Ophthalmologe 2002;99:470–473.
   PubMed Web of Science ®Google Scholar
• Knudsen A. Short-term treatment with oral amiodarone resulting in bilateral optic neuropathy and permanent blindness. BMJ Case Reports 2017; 2017:bcr2016217436.
   Google Scholar
• Nicolas J, Hendriksen PJM, de Haan LHJ, Laura HJ, Koning R, Rietjens IMCM., Bovee RFH. In vitro detection of cardiotoxins or neurotoxins affecting ion channels or pumps using beating cardiomyocytes as alternative for animal testing. Toxicol In Vitro 2015;29:281–288.
   PubMed Web of Science ®Google Scholar
• Turovaya AY, Galenko-Yaroshevskii PA, Kade AK, Uvarov AE, Kiguradze MI, Khvitiya NG, Talulashvili DR. Effects of verapamil and amiodarone on sympathoadrenal system and balance of excitatory and inhibitory amino acids in rat medulla oblongata. Bull Exp Biol Med 2005;139:665–667.
   PubMed Web of Science ®Google Scholar
• Silver PJ, Connell MJ, Dillon KM, Cumiskey WR, Volberg WA, Ezrin AM. Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents. Cardiovasc Drugs Ther 1989;3:675–682.
   PubMed Web of Science ®Google Scholar
• Vig PJ, Desaiah D. Modulation of protein kinase C activity by amiodarone and desethylamiodarone. Neurotoxicology 1991;12:595–601.
   PubMed Web of Science ®Google Scholar
• Yano T, Itoh Y, Yamada M, Egashira N, Oishi R. Combined treatment with l-carnitine and a pan-caspase inhibitor effectively reverses amiodarone-induced injury in cultured human lung epithelial cells. Apoptosis 2008;13:543–552.
   PubMed Web of Science ®Google Scholar
• Liao R, Yan F, Zeng Z, Farhan M, Little P, Quirion R, Srivastava L, Zheng W. Amiodarone-induced retinal neuronal cell apoptosis attenuated by IGF-1 via counter regulation of the PI3k/Akt/FoxO3a pathway. Mol Neurobiol 2016;65:294–213.
   Google Scholar
• Johnson LN, Krohel GB, Thomas ER. The clinical spectrum of amiodarone-associated optic neuropathy. J Natl Med Assoc 2004;96:1477–1491.
   PubMed Web of Science ®Google Scholar
• Passman RS, Bennett CL, Purpura JM, Kapur R, Johnson LN, Raisch DW, West DP, Edwards BJ, Belknap SM, Liebling DB, Fisher MJ, Samaras AT, Jones LGA, Tulas KME, McKoy JM. Amiodarone-associated optic neuropathy: a critical review. Am J Med 2012;125:447–453.
   PubMed Web of Science ®Google Scholar
• Mindel JS. Amiodarone and optic neuropathy. Am Heart J 2008;156:411–413.
   PubMed Web of Science ®Google Scholar
• Mindel JS, Anderson J, Hellkamp A, Johnson G, Poole JE, Mark DB, Lee KL, Bardy GH, and SCD-HeFT Investigators.Absence of bilateral vision loss from amiodarone: a randomized trial. Am Heart J 2007;153:837–842.
   PubMed Web of Science ®Google Scholar
• Cheng H-C, Yeh H-J, Huang N, Chou Y‐J, Yen M‐Y, Wang A‐G. Amiodarone-associated optic neuropathy: a nationwide study. Ophthalmology 2015;122:2553–2559.
   PubMed Web of Science ®Google Scholar
• Mindel JS, Bagiella E. Re: Cheng et al.: Amiodarone-associated optic neuropathy: a nationwide study (Ophthalmology 2015;122:2553-9). Ophthalmology 2016;123:e58–e59.
   PubMedGoogle Scholar
• Mindel JS. Absence of amiodarone-associated optic neuropathy. Ophthalmology 2014;121:2074–2075.
   PubMed Web of Science ®Google Scholar
• Wang A-G, Cheng H-C. Amiodarone-associated optic neuropathy: clinical review. Neuroophthalmology 2017;41:55–58.
   PubMed Web of Science ®Google Scholar
• Macaluso DC, Shults WT, Fraunfelder FT. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol 1999;127:610–612.
   PubMed Web of Science ®Google Scholar
• Purvin V, Kawasaki A, Borruat F-X. Optic neuropathy in patients using amiodarone. Arch Ophthalmol 2006;124:696–701.
   PubMedGoogle Scholar
• Ciechanowski P, Töteberg-Harms M, Stürmer J, Kunz M, Landau K, Sturm V. Bilateral optic neuropathy after short-term treatment with intravenous amiodarone. Klin Monbl Augenheilkd 2012;229:431–432.
   PubMed Web of Science ®Google Scholar
• Mercado JL, Purvin VA, Kawasaki A, WuDunn D. Bilateral sequential nonarteritic anterior ischemic optic neuropathy: a comparison of visual outcomes in fellow eyes using quantitative analysis of goldmann visual fields. Arch Ophthalmol 2012;130:863–867.
   PubMedGoogle Scholar
• Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, Dickersin K. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134:317–328.
   Google Scholar